Cargando…
Ectopic expression of LAG‐3 in non–small‐cell lung cancer cells and its clinical significance
BACKGROUND: Lymphocyte activation gene 3 (LAG‐3, also known as CD223) is an immune checkpoint molecule expressed on various types of lymphocytes, and it is mainly involved in maintaining immune homeostasis. However, there are currently no data on LAG‐3 expression in non–small‐cell lung cancer cells....
Autores principales: | Ma, Chenglong, Sun, Xiao, Shen, Dong, Sun, Yuejun, Guan, Naifu, Qi, Chunjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307345/ https://www.ncbi.nlm.nih.gov/pubmed/32077528 http://dx.doi.org/10.1002/jcla.23244 |
Ejemplares similares
-
Expression and Clinical Significance of HER2 Gene and DNMT1 in Non-Small-Cell Lung Cancer
por: Diao, Weiying, et al.
Publicado: (2022) -
sLAG-3 in non-small-cell lung cancer patients’ serum
por: He, Yayi, et al.
Publicado: (2018) -
Aberrant expression of NEK2 and its clinical significance in non-small cell lung cancer
por: ZHONG, XINWEN, et al.
Publicado: (2014) -
Is ectopic Cushing’s syndrome underdiagnosed in patients with small cell lung cancer?
por: Piasecka, Marta, et al.
Publicado: (2022) -
HDAC9 deficiency promotes tumor progression by decreasing the CD8(+) dendritic cell infiltration of the tumor microenvironment
por: Ning, Yongling, et al.
Publicado: (2020)